Education
About Us
Working with TipRanks
Follow Us
Ge Healthcare Technologies Inc. (GEHC)
:GEHC
RESEARCH TOOLSreports
GEHC Analyst Ratings
Moderate Buy
5 Buy
2 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
GEHC Stock 12 Month Forecast
Average Price Target
$85.71
▲(21.33% Upside)
| Highest Price Target$93.00 | Average Price Target$85.71 | Lowest Price Target$74.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
TipRanks
$80
Buy
13.25%
Upside
Reiterated
08/01/25
GE Healthcare Technologies Inc. shows strong financial fundamentals and a positive corporate event profile, contributing to a solid stock score. However, technical indicators suggest bearish momentum, and some risks in market dynamics, such as tariff impacts and China market challenges, temper the overall outlook.
Stifel Nicolaus
$90
Buy
27.41%
Upside
Reiterated
08/04/25
Oppenheimer
$89
Buy
25.99%
Upside
Reiterated
07/31/25
Morgan Stanley
$78→$74
Hold
4.76%
Upside
Reiterated
07/31/25
Citi
$89→$93
Buy
31.65%
Upside
Reiterated
07/30/25
Bank of America Securities
$82
Hold
16.08%
Upside
Reiterated
07/30/25
Cautious Outlook for GE Healthcare Technologies: Hold Rating Maintained Amid Market Expectations and Trade UncertaintiesWe maintain our Neutral rating given continued uncertainty around China and tariffs. EPS guide higher on lower tariffs, still likely conservative GEHC raised its EPS guidance by $0.53 or 13% at the midpoint with 40c coming from a lower tariff headwind and 13c from commercial execution, lower tax and lower interest. The biggest tariff impact comes from bilateral US/China tariffs and GEHC’s updated guide assumes US/China rates move back to the elevated 54%/34% on Aug 12. We think GEHC has again taken a conservative approach on its expected tariff impact and we think it could be a source of EPS upside. GEHC continues to expect less tariff impact in 2026 versus 2025. We update our model for Q2 results.
BTIG
$82→$87
Buy
23.16%
Upside
Reiterated
07/14/25
Goldman Sachs
$82→$85
Buy
20.33%
Upside
Reiterated
06/10/25
UBS
$73
Hold
3.34%
Upside
Upgraded
05/05/25
J.P. Morgan
$78
Hold
10.42%
Upside
Reiterated
04/30/25
Jefferies
$110→$95
Buy
34.48%
Upside
Reiterated
04/30/25
Wells Fargo
$103→$89
Buy
25.99%
Upside
Reiterated
04/30/25
DBS
$80
Buy
13.25%
Upside
Reiterated
04/24/25
Piper Sandler
$97→$88
Buy
24.58%
Upside
Reiterated
04/23/25
Mizuho Securities
$110→$95
Buy
34.48%
Upside
Reiterated
04/16/25
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
TipRanks
$80
Buy
13.25%
Upside
Reiterated
08/01/25
GE Healthcare Technologies Inc. shows strong financial fundamentals and a positive corporate event profile, contributing to a solid stock score. However, technical indicators suggest bearish momentum, and some risks in market dynamics, such as tariff impacts and China market challenges, temper the overall outlook.
Stifel Nicolaus
$90
Buy
27.41%
Upside
Reiterated
08/04/25
Oppenheimer
$89
Buy
25.99%
Upside
Reiterated
07/31/25
Morgan Stanley
$78→$74
Hold
4.76%
Upside
Reiterated
07/31/25
Citi
$89→$93
Buy
31.65%
Upside
Reiterated
07/30/25
Bank of America Securities
$82
Hold
16.08%
Upside
Reiterated
07/30/25
Cautious Outlook for GE Healthcare Technologies: Hold Rating Maintained Amid Market Expectations and Trade UncertaintiesWe maintain our Neutral rating given continued uncertainty around China and tariffs. EPS guide higher on lower tariffs, still likely conservative GEHC raised its EPS guidance by $0.53 or 13% at the midpoint with 40c coming from a lower tariff headwind and 13c from commercial execution, lower tax and lower interest. The biggest tariff impact comes from bilateral US/China tariffs and GEHC’s updated guide assumes US/China rates move back to the elevated 54%/34% on Aug 12. We think GEHC has again taken a conservative approach on its expected tariff impact and we think it could be a source of EPS upside. GEHC continues to expect less tariff impact in 2026 versus 2025. We update our model for Q2 results.
BTIG
$82→$87
Buy
23.16%
Upside
Reiterated
07/14/25
Goldman Sachs
$82→$85
Buy
20.33%
Upside
Reiterated
06/10/25
UBS
$73
Hold
3.34%
Upside
Upgraded
05/05/25
J.P. Morgan
$78
Hold
10.42%
Upside
Reiterated
04/30/25
Jefferies
$110→$95
Buy
34.48%
Upside
Reiterated
04/30/25
Wells Fargo
$103→$89
Buy
25.99%
Upside
Reiterated
04/30/25
DBS
$80
Buy
13.25%
Upside
Reiterated
04/24/25
Piper Sandler
$97→$88
Buy
24.58%
Upside
Reiterated
04/23/25
Mizuho Securities
$110→$95
Buy
34.48%
Upside
Reiterated
04/16/25
Best Analysts Covering GE Healthcare Technologies Inc
1 Month
xxx
Success Rate
11/18 ratings generated profit
Average Return
+1.12%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 61.11% of your transactions generating a profit, with an average return of +1.12% per trade.
3 Months
xxx
Success Rate
11/18 ratings generated profit
Average Return
+2.33%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 61.11% of your transactions generating a profit, with an average return of +2.33% per trade.
1 Year
Success Rate
6/11 ratings generated profit
Average Return
+3.01%
reiterated a buy rating 9 days ago
Copying Joanne Wuensch's trades and holding each position for 1 Year would result in 54.55% of your transactions generating a profit, with an average return of +3.01% per trade.
2 Years
xxx
Success Rate
4/11 ratings generated profit
Average Return
-7.97%
reiterated a xxx
rating 9 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 36.36% of your transactions generating a profit, with an average return of -7.97% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
GEHC Analyst Recommendation Trends
Rating
Apr 25
May 25
Jun 25
Jul 25
Aug 25
Strong Buy
2
2
2
0
0
Buy
25
17
21
22
19
Hold
8
11
10
6
2
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
35
30
33
28
21
Each month's total comprises the sum of three months' worth of ratings.
GEHC Financial Forecast
GEHC Stock Forecast FAQ
What is GEHC’s average 12-month price target, according to analysts?
Based on analyst ratings, Ge Healthcare Technologies Inc.’s 12-month average price target is 85.71.
What is GEHC’s upside potential, based on the analysts’ average price target?
Ge Healthcare Technologies Inc. has 21.33% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is GEHC a Buy, Sell or Hold?
Ge Healthcare Technologies Inc. has a consensus rating of Moderate Buy which is based on 5 buy ratings, 2 hold ratings and 0 sell ratings.
What is Ge Healthcare Technologies Inc.’s price target?
The average price target for Ge Healthcare Technologies Inc. is 85.71. This is based on 7 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $93.00 ,the lowest forecast is $74.00. The average price target represents 21.33% Increase from the current price of $70.64.
The highest analyst price target is $93.00 ,the lowest forecast is $74.00. The average price target represents 21.33% Increase from the current price of $70.64.
What do analysts say about Ge Healthcare Technologies Inc.?
Ge Healthcare Technologies Inc.’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 7 Wall Streets Analysts.
How can I buy shares of GEHC?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.